Medtronic plc stock edges higher as MiniMed spin-off exchange offer is clarified
Published on 09/18/2026 at 14:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Medtronic plc stock (ISIN IE00BTN1Y115) closed at USD 92.77 on the New York Stock Exchange on September 17, 2026, while the company refined key details of its ongoing exchange offer to complete the separation of its diabetes business MiniMed Group.
Exchange offer clarifies terms of MiniMed separation
As StockTitan reports, Medtronic launched an exchange offer on September 14, 2026 to separate most of MiniMed Group, offering to exchange Medtronic ordinary shares for up to 225,361,295 newly issued MiniMed common shares, representing about 80.1% of MiniMed’s outstanding shares as of September 3, 2026.
According to StockTitan, if the offer is oversubscribed Medtronic may accept up to an additional 27,452,053 MiniMed shares, roughly 2% of Medtronic’s total outstanding ordinary shares, corresponding to its remaining interest in MiniMed that could be exchanged.
Typographical error correction reduces execution risk
On September 17, 2026, Medtronic filed a Form 8-K to correct a typographical error in the prospectus describing the guaranteed-delivery deadline for the exchange offer, a change highlighted by GuruFocus.
As StockTitan explains, the corrected language confirms that a guaranteed-delivery notice for tendered Medtronic shares expires at 5:00 p.m. New York time on the second New York Stock Exchange trading day after execution, clarifying timing for shareholders considering participation in the MiniMed exchange.
Recent earnings show double-digit growth
In the backdrop of the MiniMed separation, Medtronic’s latest reported figures show the medical-device group entering fiscal 2027 with solid momentum. As The Motley Fool notes, Medtronic delivered double-digit revenue and earnings per share growth in the first quarter of fiscal 2027, indicating that core operations are expanding even as the company reshapes its portfolio.
Per a Reuters-based analysis reported on September 1, 2026, Medtronic raised the lower end of its fiscal 2027 profit forecast and its revenue growth outlook on the back of strong demand for heart devices, according to Yahoo Finance, underscoring a favorable earnings backdrop for the stock.
Analyst view and valuation context
The stock’s valuation has also drawn attention in recent days. According to GuruFocus, a recent insider transaction on September 16, 2026 was executed at a price of USD 93.65 per share, compared with a GF Value estimate of USD 100.63, implying a price-to-GF-Value ratio of 0.93 that suggests the shares are fairly valued relative to that metric.
As MarketBeat summarizes, nineteen investment analysts currently rate Medtronic stock as a Buy and nine as a Hold, producing an average rating of Moderate Buy and a consensus target price of USD 103.92, which stands about 11.4% above the recent closing level of USD 92.77.
Dividend ex-date and income profile
Beyond growth and portfolio moves, Medtronic’s dividend remains a key part of the investment case. Per data from Yahoo Finance, Medtronic has declared a cash dividend of USD 0.72 per share with an ex-dividend date of September 25, 2026, corresponding to an annualized payout of USD 2.88 and a yield around 3.1% on recent prices.
Commentary from NAI500 highlights Medtronic’s progress toward so-called Dividend King status, emphasizing the combination of its expanding Hugo robotic-assisted surgery system and its long track record of dividend growth as dual drivers for both growth and income-oriented investors.
Stock price and market metrics
Medtronic plc stock last closed at USD 92.77 on the New York Stock Exchange on September 17, 2026, with an after-hours indication around USD 93.00 later that evening, according to recent price data, placing the shares below the consensus analyst target of USD 103.92 and below the USD 93.65 level of the latest reported insider sale.
Medtronic plc stock snapshot
- Company: Medtronic plc
- ISIN: IE00BTN1Y115
- Ticker: MDT
- Trading venue: NYSE
- Price (as of September 17, 2026, 4:00): 92.77 USD
- Market capitalization: 118,700,000,000 USD (as of September 17, 2026)
- Sector / Industry: Health Care / Medical Devices
- Index membership: S&P 500
- Next earnings date:
